TREATMENT SATISFACTION COMPARISON IN RHEUMATOID ARTHRITIS PATIENTS BETWEEN TOFACITINIB CITRATE AND ADALIMUMAB, EACH USED IN RHEUMATOID ARTHRITIS TREATMENT
Phase of Trial: Phase IV
Latest Information Update: 29 Jan 2019
At a glance
- Drugs Adalimumab (Primary) ; Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 18 Jan 2019 Planned End Date changed from 30 Nov 2018 to 1 Mar 2019.
- 18 Jan 2019 Planned primary completion date changed from 30 Nov 2018 to 1 Mar 2019.
- 18 Oct 2018 New trial record